As of 2026-07-17, the Relative Valuation of Guardant Health Inc (GH) is (79.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 155.00 USD, the upside of Guardant Health Inc based on Relative Valuation is -151.6%.
The range of the Relative Valuation is (81.02) - (78.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.8x - 32.7x | 27.1x |
| Forward P/E multiples | 20.4x - 24.2x | 21.8x |
| Fair Price | (81.02) - (78.99) | (79.96) |
| Upside | -152.3% - -151.0% | -151.6% |
| Date | P/E |
| 2026-07-15 | -49.88 |
| 2026-07-14 | -49.01 |
| 2026-07-13 | -48.49 |
| 2026-07-10 | -48.99 |
| 2026-07-09 | -50.22 |
| 2026-07-08 | -47.80 |
| 2026-07-07 | -49.87 |
| 2026-07-06 | -51.68 |
| 2026-07-02 | -51.42 |
| 2026-07-01 | -52.27 |
| 2026-06-30 | -45.92 |
| 2026-06-29 | -47.06 |
| 2026-06-26 | -45.68 |
| 2026-06-25 | -43.75 |
| 2026-06-24 | -41.92 |
| 2026-06-23 | -40.05 |
| 2026-06-22 | -39.43 |
| 2026-06-18 | -40.34 |
| 2026-06-17 | -39.52 |
| 2026-06-16 | -38.98 |
| 2026-06-15 | -39.74 |
| 2026-06-12 | -40.29 |
| 2026-06-11 | -40.07 |
| 2026-06-10 | -40.01 |
| 2026-06-09 | -39.83 |
| 2026-06-08 | -38.23 |
| 2026-06-05 | -38.45 |
| 2026-06-04 | -40.73 |
| 2026-06-03 | -38.88 |
| 2026-06-02 | -39.84 |
| 2026-06-01 | -39.53 |
| 2026-05-29 | -39.70 |
| 2026-05-28 | -40.78 |
| 2026-05-27 | -39.03 |
| 2026-05-26 | -36.69 |
| 2026-05-22 | -36.41 |
| 2026-05-21 | -36.12 |
| 2026-05-20 | -35.19 |
| 2026-05-19 | -30.06 |
| 2026-05-18 | -29.28 |
| 2026-05-15 | -29.05 |
| 2026-05-14 | -30.20 |
| 2026-05-13 | -30.14 |
| 2026-05-12 | -30.59 |
| 2026-05-11 | -29.60 |
| 2026-05-08 | -29.29 |
| 2026-05-07 | -28.24 |
| 2026-05-06 | -28.24 |
| 2026-05-05 | -27.40 |
| 2026-05-04 | -27.91 |